The effect of transforming growth factor beta 1 on the function of HepG2 hepatoma cells.
Grant
H
H
Bioengineering Unit, University of Strathclyde, Glasgow.
Anderson
K
K
Nugent
C
C
Rodgers
H
H
D006528:Carcinoma, Hepatocellular; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D019363:Cytochrome P-450 CYP1A1 / Q000378:metabolism*; D019362:Cytochrome P-450 CYP2B1 / Q000378:metabolism*; D008058:Dihydrolipoamide Dehydrogenase / Q000378:metabolism; D014453:Glucuronosyltransferase / Q000378:metabolism*; D005982:Glutathione Transferase / Q000378:metabolism; D006801:Humans; D007527:Isoenzymes / Q000378:metabolism; D007700:Kinetics; D008113:Liver Neoplasms; D016212:Transforming Growth Factor beta / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D007527:Isoenzymes; D016212:Transforming Growth Factor beta; C019787:bilirubin glucuronoside glucuronosyltransferase; D019363:Cytochrome P-450 CYP1A1; D019362:Cytochrome P-450 CYP2B1; D008058:Dihydrolipoamide Dehydrogenase; D014453:Glucuronosyltransferase; D005982:Glutathione Transferase